Barbro Kjellstrom
Overview
Explore the profile of Barbro Kjellstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
872
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hjalmarsson C, Thakur T, Weiss T, Bjorklund E, Papageorgiou J, Radegran G, et al.
J Heart Lung Transplant
. 2024 Nov;
PMID: 39536922
Background: Multicomponent improvement (MCI) is a novel endpoint for predicting survival in patients with pulmonary arterial hypertension (PAH), included in the sotatercept clinical program. For the first time, we investigated...
2.
Lindholm A, Kjellstrom B, Radegran G, Arheden H, Ostenfeld E
J Cardiovasc Magn Reson
. 2024 Sep;
26(2):101103.
PMID: 39326558
Background: Right ventricular (RV) dyssynchrony or post systolic contraction (PSC) causes inefficient pumping and has not been investigated as a prognostic marker in pulmonary arterial hypertension (PAH). The objective was...
3.
Norhammar A, Nasman P, Buhlin K, de Faire U, Ferrannini G, Gustafsson A, et al.
J Clin Periodontol
. 2024 Sep;
52(1):16-23.
PMID: 39261983
Background And Aim: The study 'Periodontitis and Its Relation to Coronary Artery Disease' (PAROKRANK) reported an association between periodontitis (PD) and the first myocardial infarction (MI). This follow-up study aims...
4.
Venkateshvaran A, Bohlin J, Kjellstrom B, Bergstrom E, Nelsson A, Evaldsson A, et al.
Sci Rep
. 2024 Jul;
14(1):17280.
PMID: 39068288
The pathophysiology underlying impaired LV function in PAH remains unclear, with some studies implicating intrinsic myocardial dysfunction and others pointing to LV underfilling. Evaluation of pulmonary vein area (PVA) and...
5.
Ivarsson B, Johansson A, Kjellstrom B
Pulm Circ
. 2024 Feb;
14(1):e12349.
PMID: 38420145
Symptoms associated with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) impact patient's health-related quality of life (HRQoL). Studies on change and if a minimal clinically important difference...
6.
Lindholm A, Kjellstrom B, Seemann F, Carlsson M, Hesselstrand R, Radegran G, et al.
Int J Cardiovasc Imaging
. 2023 Sep;
38(10):2235-2248.
PMID: 37726454
To investigate if left and right atrioventricular plane displacement (AVPD) or regional contributions to SV are prognostic for outcome in patients with pulmonary arterial hypertension (PAH). Seventy-one patients with PAH...
7.
Kjellstrom B, Runheim H, Beaudet A, Husberg M, Ivarsson B, Pillai N, et al.
Pulm Circ
. 2023 Jun;
13(2):e12254.
PMID: 37362560
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but serious complication after a pulmonary embolism. Healthcare resource utilization (HCRU; hospitalization, outpatient visits, and drug utilization) as well as productivity loss...
8.
Runheim H, Kjellstrom B, Beaudet A, Ivarsson B, Husberg M, Pillai N, et al.
Pulm Circ
. 2023 Jan;
13(1):e12190.
PMID: 36704610
Pulmonary arterial hypertension (PAH) is a progressive disease with no cure. Healthcare resource utilization (HCRU; hospitalization, outpatient visits, and drug utilization) before diagnosis and productivity loss (sick leave and disability...
9.
Norell P, Ivarsson B, Selin M, Kjellstrom B
Pulm Circ
. 2022 Oct;
12(3):e12114.
PMID: 36203946
Polypharmacy increases the risk of drug-drug interactions that may disturb treatment effects. The aim of this study was to investigate the frequency of codispensing of potentially interacting or contraindicated drugs...
10.
Ferrannini G, Almosawi M, Buhlin K, de Faire U, Kjellstrom B, Klinge B, et al.
Scand Cardiovasc J
. 2022 Aug;
56(1):337-342.
PMID: 35974709
To explore long-term cardiovascular outcomes and mortality in patients after a first myocardial infarction (MI) compared with matched controls in a contemporary setting. . During 2010-2014 the Swedish study PAROKRANK...